nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—Eosinophilia—Leflunomide—systemic scleroderma	0.00416	0.00416	CcSEcCtD
Carbimazole—Hepatitis—Captopril—systemic scleroderma	0.00408	0.00408	CcSEcCtD
Carbimazole—Haemolytic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00405	0.00405	CcSEcCtD
Carbimazole—Myalgia—Pentoxifylline—systemic scleroderma	0.00399	0.00399	CcSEcCtD
Carbimazole—Pancytopenia—Leflunomide—systemic scleroderma	0.00399	0.00399	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—systemic scleroderma	0.00396	0.00396	CcSEcCtD
Carbimazole—Discomfort—Pentoxifylline—systemic scleroderma	0.00394	0.00394	CcSEcCtD
Carbimazole—Neutropenia—Leflunomide—systemic scleroderma	0.00393	0.00393	CcSEcCtD
Carbimazole—Contusion—Prednisone—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Carbimazole—Pancytopenia—Mycophenolic acid—systemic scleroderma	0.00381	0.00381	CcSEcCtD
Carbimazole—Infection—Pentoxifylline—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Carbimazole—Neutropenia—Mycophenolic acid—systemic scleroderma	0.00375	0.00375	CcSEcCtD
Carbimazole—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00375	0.00375	CcSEcCtD
Carbimazole—Skin disorder—Pentoxifylline—systemic scleroderma	0.00372	0.00372	CcSEcCtD
Carbimazole—Agranulocytosis—Azathioprine—systemic scleroderma	0.0037	0.0037	CcSEcCtD
Carbimazole—Angioedema—Mometasone—systemic scleroderma	0.0037	0.0037	CcSEcCtD
Carbimazole—Stomatitis—Leflunomide—systemic scleroderma	0.00365	0.00365	CcSEcCtD
Carbimazole—Jaundice—Leflunomide—systemic scleroderma	0.00365	0.00365	CcSEcCtD
Carbimazole—Alopecia—Captopril—systemic scleroderma	0.00361	0.00361	CcSEcCtD
Carbimazole—Haemoglobin—Azathioprine—systemic scleroderma	0.00358	0.00358	CcSEcCtD
Carbimazole—Eosinophilia—Lisinopril—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Carbimazole—Haemorrhage—Azathioprine—systemic scleroderma	0.00356	0.00356	CcSEcCtD
Carbimazole—Agranulocytosis—Leflunomide—systemic scleroderma	0.0035	0.0035	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Carbimazole—Stomatitis—Mycophenolic acid—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Carbimazole—Jaundice—Mycophenolic acid—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Carbimazole—Arthralgia—Mometasone—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Carbimazole—Myalgia—Mometasone—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Carbimazole—Pancytopenia—Lisinopril—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Carbimazole—Haemoglobin—Leflunomide—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Carbimazole—Liver function test abnormal—Mycophenolate mofetil—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Carbimazole—Neutropenia—Lisinopril—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Carbimazole—Haemorrhage—Leflunomide—systemic scleroderma	0.00336	0.00336	CcSEcCtD
Carbimazole—Hepatitis—Leflunomide—systemic scleroderma	0.00336	0.00336	CcSEcCtD
Carbimazole—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00333	0.00333	CcSEcCtD
Carbimazole—Ill-defined disorder—Captopril—systemic scleroderma	0.0033	0.0033	CcSEcCtD
Carbimazole—Infection—Mometasone—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Carbimazole—Angioedema—Captopril—systemic scleroderma	0.00325	0.00325	CcSEcCtD
Carbimazole—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Carbimazole—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Carbimazole—Hepatitis—Mycophenolic acid—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Carbimazole—Malaise—Captopril—systemic scleroderma	0.0032	0.0032	CcSEcCtD
Carbimazole—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Carbimazole—Alopecia—Azathioprine—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Carbimazole—Jaundice—Lisinopril—systemic scleroderma	0.00314	0.00314	CcSEcCtD
Carbimazole—Urticaria—Pentoxifylline—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Carbimazole—Myalgia—Captopril—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Carbimazole—Arthralgia—Captopril—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Carbimazole—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Carbimazole—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.003	0.003	CcSEcCtD
Carbimazole—Agranulocytosis—Lisinopril—systemic scleroderma	0.003	0.003	CcSEcCtD
Carbimazole—Discomfort—Captopril—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Carbimazole—Alopecia—Leflunomide—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Carbimazole—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Carbimazole—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00291	0.00291	CcSEcCtD
Carbimazole—Hepatitis—Lisinopril—systemic scleroderma	0.00289	0.00289	CcSEcCtD
Carbimazole—Ill-defined disorder—Azathioprine—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Carbimazole—Thrombocytopenia—Captopril—systemic scleroderma	0.00284	0.00284	CcSEcCtD
Carbimazole—Alopecia—Mycophenolic acid—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Carbimazole—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Carbimazole—Malaise—Azathioprine—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Carbimazole—Leukopenia—Azathioprine—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Carbimazole—Stomatitis—Mycophenolate mofetil—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Carbimazole—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Carbimazole—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Carbimazole—Pruritus—Pentoxifylline—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Carbimazole—Aplastic anaemia—Methotrexate—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Carbimazole—Angioedema—Leflunomide—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Carbimazole—Malaise—Leflunomide—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Carbimazole—Arthralgia—Azathioprine—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Carbimazole—Myalgia—Azathioprine—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Carbimazole—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Carbimazole—Angiopathy—Lisinopril—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Carbimazole—Leukopenia—Leflunomide—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Carbimazole—Body temperature increased—Mometasone—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Carbimazole—Discomfort—Azathioprine—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Carbimazole—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Carbimazole—Mouth ulceration—Methotrexate—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Carbimazole—Alopecia—Lisinopril—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Carbimazole—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Carbimazole—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Carbimazole—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Carbimazole—Malaise—Mycophenolic acid—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Carbimazole—Infection—Azathioprine—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Carbimazole—Leukopenia—Mycophenolic acid—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Carbimazole—Arthralgia—Leflunomide—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Carbimazole—Myalgia—Leflunomide—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Carbimazole—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Carbimazole—Discomfort—Leflunomide—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Carbimazole—Skin disorder—Azathioprine—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Carbimazole—Rash—Pentoxifylline—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Carbimazole—Dermatitis—Pentoxifylline—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Carbimazole—Headache—Pentoxifylline—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Carbimazole—Feeling abnormal—Captopril—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Carbimazole—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Carbimazole—Myalgia—Mycophenolic acid—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Carbimazole—Infection—Leflunomide—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Carbimazole—Discomfort—Mycophenolic acid—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Carbimazole—Nervous system disorder—Leflunomide—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Carbimazole—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Carbimazole—Pruritus—Mometasone—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Carbimazole—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Carbimazole—Skin disorder—Leflunomide—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Carbimazole—Angioedema—Lisinopril—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Carbimazole—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Carbimazole—Body temperature increased—Captopril—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Carbimazole—Nausea—Pentoxifylline—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Carbimazole—Malaise—Lisinopril—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Carbimazole—Infection—Mycophenolic acid—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Carbimazole—Leukopenia—Lisinopril—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Carbimazole—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Carbimazole—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Carbimazole—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Carbimazole—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Carbimazole—Myalgia—Lisinopril—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Carbimazole—Arthralgia—Lisinopril—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Carbimazole—Discomfort—Lisinopril—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Carbimazole—Feeling abnormal—Azathioprine—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Carbimazole—Rash—Mometasone—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Carbimazole—Dermatitis—Mometasone—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Carbimazole—Headache—Mometasone—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Carbimazole—Pruritus—Captopril—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Carbimazole—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Carbimazole—Infection—Lisinopril—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Carbimazole—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Carbimazole—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Carbimazole—Neutropenia—Prednisone—systemic scleroderma	0.002	0.002	CcSEcCtD
Carbimazole—Body temperature increased—Azathioprine—systemic scleroderma	0.002	0.002	CcSEcCtD
Carbimazole—Skin disorder—Lisinopril—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Carbimazole—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Carbimazole—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Carbimazole—Feeling abnormal—Leflunomide—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Carbimazole—Nausea—Mometasone—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Carbimazole—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Carbimazole—Urticaria—Leflunomide—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Carbimazole—Body temperature increased—Leflunomide—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Carbimazole—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Carbimazole—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Carbimazole—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Carbimazole—Hypersensitivity—Azathioprine—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Carbimazole—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Carbimazole—Rash—Captopril—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Carbimazole—Dermatitis—Captopril—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Carbimazole—Headache—Captopril—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Carbimazole—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Carbimazole—Infection—Mycophenolate mofetil—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Carbimazole—Eosinophilia—Methotrexate—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Carbimazole—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Carbimazole—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Carbimazole—Hypersensitivity—Leflunomide—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Carbimazole—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Carbimazole—Haemoglobin—Prednisone—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Carbimazole—Nausea—Captopril—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Carbimazole—Haemorrhage—Prednisone—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Carbimazole—Pancytopenia—Methotrexate—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Carbimazole—Feeling abnormal—Lisinopril—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Carbimazole—Pruritus—Leflunomide—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Carbimazole—Neutropenia—Methotrexate—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Carbimazole—Urticaria—Lisinopril—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Carbimazole—Body temperature increased—Lisinopril—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Carbimazole—Pruritus—Mycophenolic acid—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Carbimazole—Rash—Azathioprine—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Carbimazole—Dermatitis—Azathioprine—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Carbimazole—Headache—Azathioprine—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Carbimazole—Stomatitis—Methotrexate—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Carbimazole—Angiopathy—Prednisone—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Carbimazole—Alopecia—Prednisone—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Carbimazole—Hypersensitivity—Lisinopril—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Carbimazole—Rash—Leflunomide—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Carbimazole—Dermatitis—Leflunomide—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Carbimazole—Nausea—Azathioprine—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Carbimazole—Headache—Leflunomide—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Carbimazole—Agranulocytosis—Methotrexate—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Carbimazole—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Carbimazole—Pruritus—Lisinopril—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Carbimazole—Haemoglobin—Methotrexate—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Carbimazole—Rash—Mycophenolic acid—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Carbimazole—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Carbimazole—Haemorrhage—Methotrexate—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Carbimazole—Hepatitis—Methotrexate—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Carbimazole—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Carbimazole—Headache—Mycophenolic acid—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Carbimazole—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Carbimazole—Nausea—Leflunomide—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Carbimazole—Ill-defined disorder—Prednisone—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Carbimazole—Angioedema—Prednisone—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Carbimazole—Nausea—Mycophenolic acid—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Carbimazole—Malaise—Prednisone—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Carbimazole—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Carbimazole—Angiopathy—Methotrexate—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Carbimazole—Rash—Lisinopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Carbimazole—Dermatitis—Lisinopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Carbimazole—Headache—Lisinopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Carbimazole—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Carbimazole—Arthralgia—Prednisone—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Carbimazole—Myalgia—Prednisone—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Carbimazole—Alopecia—Methotrexate—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Carbimazole—Discomfort—Prednisone—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Carbimazole—Nausea—Lisinopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Carbimazole—Infection—Prednisone—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Carbimazole—Nervous system disorder—Prednisone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Carbimazole—Skin disorder—Prednisone—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Carbimazole—Ill-defined disorder—Methotrexate—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Carbimazole—Rash—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Carbimazole—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Carbimazole—Headache—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Carbimazole—Malaise—Methotrexate—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Carbimazole—Leukopenia—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Carbimazole—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Carbimazole—Arthralgia—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Carbimazole—Myalgia—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Carbimazole—Discomfort—Methotrexate—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Carbimazole—Infection—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Carbimazole—Feeling abnormal—Prednisone—systemic scleroderma	0.001	0.001	CcSEcCtD
Carbimazole—Nervous system disorder—Methotrexate—systemic scleroderma	0.000999	0.000999	CcSEcCtD
Carbimazole—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000998	0.000998	CcSEcCtD
Carbimazole—Skin disorder—Methotrexate—systemic scleroderma	0.00099	0.00099	CcSEcCtD
Carbimazole—Urticaria—Prednisone—systemic scleroderma	0.000969	0.000969	CcSEcCtD
Carbimazole—Body temperature increased—Prednisone—systemic scleroderma	0.000964	0.000964	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000928	0.000928	CcSEcCtD
Carbimazole—Hypersensitivity—Prednisone—systemic scleroderma	0.000898	0.000898	CcSEcCtD
Carbimazole—Pruritus—Prednisone—systemic scleroderma	0.000863	0.000863	CcSEcCtD
Carbimazole—Feeling abnormal—Methotrexate—systemic scleroderma	0.00084	0.00084	CcSEcCtD
Carbimazole—Urticaria—Methotrexate—systemic scleroderma	0.000809	0.000809	CcSEcCtD
Carbimazole—Body temperature increased—Methotrexate—systemic scleroderma	0.000806	0.000806	CcSEcCtD
Carbimazole—Rash—Prednisone—systemic scleroderma	0.000769	0.000769	CcSEcCtD
Carbimazole—Dermatitis—Prednisone—systemic scleroderma	0.000768	0.000768	CcSEcCtD
Carbimazole—Headache—Prednisone—systemic scleroderma	0.000764	0.000764	CcSEcCtD
Carbimazole—Hypersensitivity—Methotrexate—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Carbimazole—Nausea—Prednisone—systemic scleroderma	0.000724	0.000724	CcSEcCtD
Carbimazole—Pruritus—Methotrexate—systemic scleroderma	0.000721	0.000721	CcSEcCtD
Carbimazole—Rash—Methotrexate—systemic scleroderma	0.000642	0.000642	CcSEcCtD
Carbimazole—Dermatitis—Methotrexate—systemic scleroderma	0.000642	0.000642	CcSEcCtD
Carbimazole—Headache—Methotrexate—systemic scleroderma	0.000638	0.000638	CcSEcCtD
Carbimazole—Nausea—Methotrexate—systemic scleroderma	0.000605	0.000605	CcSEcCtD
